OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial

OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Retrovirology 2009-10, Vol.6 (S3), p.O27-O27, Article O27
Hauptverfasser: Currier, JR, De Souza, M, Ratto-Kim, S, Paris, R, Nguay, V, Cox, J, Earl, P, Moss, B, Sriplienchan, S, Thongcharoen, P, Kim, J, Robb, M, Michael, N, Marovich, M
Format: Artikel
Sprache:eng
Schlagworte:
Oral Presentation
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page O27
container_issue S3
container_start_page O27
container_title Retrovirology
container_volume 6
creator Currier, JR
De Souza, M
Ratto-Kim, S
Paris, R
Nguay, V
Cox, J
Earl, P
Moss, B
Sriplienchan, S
Thongcharoen, P
Kim, J
Robb, M
Michael, N
Marovich, M
description
doi_str_mv 10.1186/1742-4690-6-S3-O27
format Article
fullrecord <record><control><sourceid>biomedcentral_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2767548</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_biomedcentral_com_1742_4690_6_S3_O27</sourcerecordid><originalsourceid>FETCH-LOGICAL-b3237-4cd9f9d24fd75f507d561353a0f9d83245e8aa469710f9cc8623ec49fee604f13</originalsourceid><addsrcrecordid>eNp1kctKAzEUhgdR8PoCrrLURTSZZC7dCKV4KShdeNmGM5kTG51JSjIK9T18X1MroqCrhO9PPjjnz7JDzk44r8tTXsmcynLEaElvBZ3l1Ua28w03f9y3s90YnxgTvGb1TvY-GzNJmTghkzkE0AMG-waD9Y54QzR2He2xtTBgS2zfvzgkAePCu4iRPKLD8Bk1y4S17xvrwA2k9601NvFX0No6C2TsnpOeHIWbh_ExvZo-UE6sI0AWc4hIpl8vkQzBQrefbRnoIh58nXvZ_cX53eSKXs8up5PxNW1ELioqdTsyozaXpq0KU7CqLUouCgEs0VrkssAaIE1d8US0rstcoJYjg1gyabjYy87W3sVLk8bU6IYAnVoE20NYKg9W_U6cnatH_6ryqqwKWSfB-VrQWP-P4HeSdqRWXahVF6pUt0KlspInX3t08DEGNN8KztSq4b8-fQB_KZvz</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Currier, JR ; De Souza, M ; Ratto-Kim, S ; Paris, R ; Nguay, V ; Cox, J ; Earl, P ; Moss, B ; Sriplienchan, S ; Thongcharoen, P ; Kim, J ; Robb, M ; Michael, N ; Marovich, M</creator><creatorcontrib>Currier, JR ; De Souza, M ; Ratto-Kim, S ; Paris, R ; Nguay, V ; Cox, J ; Earl, P ; Moss, B ; Sriplienchan, S ; Thongcharoen, P ; Kim, J ; Robb, M ; Michael, N ; Marovich, M</creatorcontrib><identifier>ISSN: 1742-4690</identifier><identifier>EISSN: 1742-4690</identifier><identifier>DOI: 10.1186/1742-4690-6-S3-O27</identifier><language>eng</language><publisher>BioMed Central Ltd</publisher><subject>Oral Presentation</subject><ispartof>Retrovirology, 2009-10, Vol.6 (S3), p.O27-O27, Article O27</ispartof><rights>Copyright © 2009 Currier et al; licensee BioMed Central Ltd. 2009 Currier et al; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b3237-4cd9f9d24fd75f507d561353a0f9d83245e8aa469710f9cc8623ec49fee604f13</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767548/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767548/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27923,27924,53790,53792</link.rule.ids></links><search><creatorcontrib>Currier, JR</creatorcontrib><creatorcontrib>De Souza, M</creatorcontrib><creatorcontrib>Ratto-Kim, S</creatorcontrib><creatorcontrib>Paris, R</creatorcontrib><creatorcontrib>Nguay, V</creatorcontrib><creatorcontrib>Cox, J</creatorcontrib><creatorcontrib>Earl, P</creatorcontrib><creatorcontrib>Moss, B</creatorcontrib><creatorcontrib>Sriplienchan, S</creatorcontrib><creatorcontrib>Thongcharoen, P</creatorcontrib><creatorcontrib>Kim, J</creatorcontrib><creatorcontrib>Robb, M</creatorcontrib><creatorcontrib>Michael, N</creatorcontrib><creatorcontrib>Marovich, M</creatorcontrib><title>OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial</title><title>Retrovirology</title><subject>Oral Presentation</subject><issn>1742-4690</issn><issn>1742-4690</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp1kctKAzEUhgdR8PoCrrLURTSZZC7dCKV4KShdeNmGM5kTG51JSjIK9T18X1MroqCrhO9PPjjnz7JDzk44r8tTXsmcynLEaElvBZ3l1Ua28w03f9y3s90YnxgTvGb1TvY-GzNJmTghkzkE0AMG-waD9Y54QzR2He2xtTBgS2zfvzgkAePCu4iRPKLD8Bk1y4S17xvrwA2k9601NvFX0No6C2TsnpOeHIWbh_ExvZo-UE6sI0AWc4hIpl8vkQzBQrefbRnoIh58nXvZ_cX53eSKXs8up5PxNW1ELioqdTsyozaXpq0KU7CqLUouCgEs0VrkssAaIE1d8US0rstcoJYjg1gyabjYy87W3sVLk8bU6IYAnVoE20NYKg9W_U6cnatH_6ryqqwKWSfB-VrQWP-P4HeSdqRWXahVF6pUt0KlspInX3t08DEGNN8KztSq4b8-fQB_KZvz</recordid><startdate>20091022</startdate><enddate>20091022</enddate><creator>Currier, JR</creator><creator>De Souza, M</creator><creator>Ratto-Kim, S</creator><creator>Paris, R</creator><creator>Nguay, V</creator><creator>Cox, J</creator><creator>Earl, P</creator><creator>Moss, B</creator><creator>Sriplienchan, S</creator><creator>Thongcharoen, P</creator><creator>Kim, J</creator><creator>Robb, M</creator><creator>Michael, N</creator><creator>Marovich, M</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20091022</creationdate><title>OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial</title><author>Currier, JR ; De Souza, M ; Ratto-Kim, S ; Paris, R ; Nguay, V ; Cox, J ; Earl, P ; Moss, B ; Sriplienchan, S ; Thongcharoen, P ; Kim, J ; Robb, M ; Michael, N ; Marovich, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b3237-4cd9f9d24fd75f507d561353a0f9d83245e8aa469710f9cc8623ec49fee604f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Oral Presentation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Currier, JR</creatorcontrib><creatorcontrib>De Souza, M</creatorcontrib><creatorcontrib>Ratto-Kim, S</creatorcontrib><creatorcontrib>Paris, R</creatorcontrib><creatorcontrib>Nguay, V</creatorcontrib><creatorcontrib>Cox, J</creatorcontrib><creatorcontrib>Earl, P</creatorcontrib><creatorcontrib>Moss, B</creatorcontrib><creatorcontrib>Sriplienchan, S</creatorcontrib><creatorcontrib>Thongcharoen, P</creatorcontrib><creatorcontrib>Kim, J</creatorcontrib><creatorcontrib>Robb, M</creatorcontrib><creatorcontrib>Michael, N</creatorcontrib><creatorcontrib>Marovich, M</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Retrovirology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Currier, JR</au><au>De Souza, M</au><au>Ratto-Kim, S</au><au>Paris, R</au><au>Nguay, V</au><au>Cox, J</au><au>Earl, P</au><au>Moss, B</au><au>Sriplienchan, S</au><au>Thongcharoen, P</au><au>Kim, J</au><au>Robb, M</au><au>Michael, N</au><au>Marovich, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial</atitle><jtitle>Retrovirology</jtitle><date>2009-10-22</date><risdate>2009</risdate><volume>6</volume><issue>S3</issue><spage>O27</spage><epage>O27</epage><pages>O27-O27</pages><artnum>O27</artnum><issn>1742-4690</issn><eissn>1742-4690</eissn><pub>BioMed Central Ltd</pub><doi>10.1186/1742-4690-6-S3-O27</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1742-4690
ispartof Retrovirology, 2009-10, Vol.6 (S3), p.O27-O27, Article O27
issn 1742-4690
1742-4690
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2767548
source DOAJ Directory of Open Access Journals; PubMed Central Open Access; Springer Nature OA Free Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings
subjects Oral Presentation
title OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T12%3A05%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-biomedcentral_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=OA04-03.%20Characterization%20of%20cell-mediated%20immune%20responses%20generated%20by%20recombinant%20modified%20vaccinia%20Ankara%20(rMVA)-HIV-1%20in%20a%20phase%20I%20vaccine%20trial&rft.jtitle=Retrovirology&rft.au=Currier,%20JR&rft.date=2009-10-22&rft.volume=6&rft.issue=S3&rft.spage=O27&rft.epage=O27&rft.pages=O27-O27&rft.artnum=O27&rft.issn=1742-4690&rft.eissn=1742-4690&rft_id=info:doi/10.1186/1742-4690-6-S3-O27&rft_dat=%3Cbiomedcentral_pubme%3Eoai_biomedcentral_com_1742_4690_6_S3_O27%3C/biomedcentral_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true